SCHEMBL8091483

SCHEMBL8091483

COc1c(CCCc2ccccc2)[c]c(CCCc2cccc(C(=O)O)c2)c(OC)c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 6/20 0.48
TP53 P04637 1/20 0.46
PKM P14618 1/20 0.46
NFKB1 P19838 1/20 0.46
RAB9A P51151 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
PDE4A P27815 1/20 0.45
PDE4B Q07343 1/20 0.45
PDE4C Q08493 1/20 0.45
PDE4D Q08499 1/20 0.45
CYP4F2 P78329 1/20 0.44
CYP4A11 Q02928 1/20 0.44
AKR1C3 P42330 3/20 0.43
LPAR1 Q92633 2/20 0.43
FOLH1 Q04609 1/20 0.42
SLC16A3 O15427 1/20 0.41
NR1H4 Q96RI1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8091561 0.88 PTGER1 (0.49) RAB9APDE4APDE4BPDE4CPDE4D
SCHEMBL6567905 0.84 HTR2A (0.41)
SCHEMBL8090038 0.81 ABCB1 (0.39)
SCHEMBL1980273 0.81 FOLH1 (0.61) MRGPRX4RAB9ASMN1; SMN2AKR1C3FOLH1
SCHEMBL16559877 0.78 FOLH1 (0.66) MRGPRX4RAB9ACYP4F2CYP4A11FOLH1
SCHEMBL7434046 0.77 TDP1 (0.51) RAB9AKMT2A
SCHEMBL8090170 0.75 TDP1 (0.49) KMT2A
SCHEMBL30395109 0.74 FOLH1 (0.66) MRGPRX4AKR1C3FOLH1KMT2A
SCHEMBL1817886 0.74 FOLH1 (0.66) MRGPRX4AKR1C3FOLH1KMT2A
SCHEMBL8091379 0.73 HTR2A (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6124328-A TREATING NERVE CELLS WITH A NEUROTROPHIC AGENT; PROMOTING REPAIR OF NEURONAL DAMAGE CAUSED BY DISEASE OR PHYSICAL TRAUMA VERTEX PHARMACEUTICALS INCORPORATED (US) 2000-09-26 US disclosed
US-6037370-A TREATING ALZHEIMER*S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, PARKINSON*S DISEASE, AND OTHER NERVOUS SYSTEM DISORDERS WITH PEPTIDE DERIVATIVES VERTEX PHARMACEUTICALS INCORPORATED (US) 2000-03-14 US disclosed